Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

toothbrush

- PMLiVE

Jazz shares positive results for Zepzelca combination in phase 3 lung cancer study

Approximately 30,000 new cases of small cell lung cancer are reported in the US every year

- PMLiVE

Inizio Medical appoints Matt Wadyka as president, US medical affairs

Wadyka most recently served as global head of scientific communications at Roche/Genentech

- PMLiVE

Cultivating Interest in Infectious Disease Education at ID Week 2024

IDWeek starts tomorrow, October 16, and Medscape is bringing outcomes and education! We are excited to announce Medscape is presenting six posters that highlight the significant impact of our educational...

Medscape Education

- PMLiVE

Eli Lilly’s mirikizumab shows promise in phase 3 Crohn’s disease study

Inflammatory bowel disease affects almost one in every 100 people in the US

- PMLiVE

Merck and Exelixis partner to evaluate new cancer combination treatments

The companies will evaluate the regimens in head and neck cancer and renal cell carcinoma

- PMLiVE

FDA advisory committee recommends Stealth’s elamipretide for Barth syndrome

The ultra-rare genetic disease affects approximately 150 people in the US

- PMLiVE

Innovative Trials appoints new Leadership Team member

Patient Recruitment company, Innovative Trials, appointed new Finance and Business Services Director

Innovative Trials

- PMLiVE

Mtech Access are exhibiting at ISPOR in Europe

• Mtech Access – Powered by Petauri™ are excited to be returning to ISPOR Europe this November. The team will be joined by colleagues from across Petauri, including Delta Hat...

Petauri Evidence

- PMLiVE

TOMORROW: Last chance to register for FREE Origins Webinar: How Patient Involvement is Transforming Clinical Trials – Reserve Your Spot Today!

Last chance to register for our exclusive webinar, “Why Patient Perspectives Matter: Driving Success in Clinical Trials”!   Wendy Erler and Alfred Samuels are ready to join Su Smith and...

Origins – The Patient Focused Specialists

- PMLiVE

Johnson & Johnson receives updated NICE recommendation for Tecvayli in multiple myeloma

Approximately 5,900 new cases of the blood cancer are diagnosed every year in the UK

- PMLiVE

Pfizer shares positive phase 3 results for Talzenna combination in prostate cancer

Up to 20% of patients will develop metastatic castration-resistant disease within five to seven years of diagnosis

- PMLiVE

Roche presents two-year data for spinal muscular atrophy treatment Evrysdi in children

The severe and progressive neuromuscular disease affects about one in every 10,000 babies

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links